Abstract
Due to the high incidence of COVID-19 case numbers internationally, the World Health Organization (WHO) declared a Public Health Emergency of global relevance, advising countries to follow protocols to combat pandemic advance through actions that can reduce spread and consequently avoid a collapse in the local health system. On March 18, 2020, Pará notified the first case of COVID-19. After seven weeks, the number of confirmed cases reached 4,756 with 375 deaths. Knowing that infected people may be asymptomatic, the disease symptomatology absence and the population’s neglect of isolation influence the spread, and factors such as chronic pneumonia, high age, obesity, chronic kidney diseases and other comorbidities favor the mortality rate. On the other hand, social isolation, quarantine and lockdown seek to contain the intraregional contagion advance. This study analyzes the dynamics of COVID-19 new cases advance among municipalities in the state of Pará, Brazil. The results show it took 49 days for 81% of the state’s municipalities to register COVID-19 cases. The association between social isolation, quarantine and lockdown as an action to contain the infection was effective in reducing the region’s new cases registration of COVID-19 in the short-term.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research received no investment for start, progress and conclusion.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data of a secondary nature. There was no need for IRB and / or ethics committee.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We declare that all data are of a secondary nature. And they were obtained on public access platforms. According available links.
https://coronavirus.saude.gov.br/sobre-a-doenca#o-que-e-covid
